2nd Annual Highly Potent Active Pharmaceutical Ingredients Summit

This premier B2B event will enable the participants to learn about the latest developments in the HPAPI industry.

This summit will be focusing on the latest market development trends in the highly potent active pharmaceutical ingredients field, global standards, innovation challenges & expectations, sustainability, emerging markets, future trends & technological developments, and outsourcing.

FACEBOOK EVENT
TAKE A LOOK VIDEO ON YOUTUBE

Key Practical Learning Points of the Summit:

  • Strategies for the early development of linker-payloads for antibody-drug conjugates
  • Study and evaluation of the new containment life cycle
  • Discussion of human operating at HPAPIs facilities
  • Analysis of the value proposition for validating exposure controls associated with the handling of APIs
  • Observing technical and operational challenges in developing highly potent cytotoxic agents in a biotech environment
  • Manufacturing considerations in the development of highly potent compounds – scalability & robustness addressing risks for the upscale of highly potent compounds
  • Opportunities to meet and network with leading professionals during interactive sessions
  • Study of proactive integration of occupational toxicology assessments into the drug development planning process

Who Should Attend: 

Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, and Investigators Specialising in:

  • Research & Development
  • Manufacturing
  • Risk Assessments
  • Laboratory Services
  • New Technologies
  • Process Development
  • Environmental, Health & Safety
  • Occupational Toxicology
  • Industrial Hygiene
  • New Products
  • Product Quality
  • Expertise
  • Innovations
  • Regulatory
  • Validation
  • Business Development
  • Partnerships and Alliances
  • Strategic Development
  • Sales Development
  • Formulation Development
  • External Supply

From Industries Including:

  • Pharmaceutical
  • Biotechnology
  • CRO
  • CMO
  • Non-profit organizations

 

Speakers
Sponsors

Previous Year Attendees

  • Pfizer Manufacturing Deutschland GmbH, Germany
    Management Trainee EHS

  • Novartis Pharma HSE & BC, Switzerland
    Sr. Toxicologist - Health Hazard Assessment

  • Pfizer Inc., Germany
    Director Chemical Development

  • ChargePoint Technology Ltd, UK
    Managing Director

  • ChargePoint Technology Ltd, UK
    Sales and Marketing Director

  • Lonza, Switzerland
    Sales & business development

  • Evonik Nutrition & Care GmbH, Germany
    Director Global Business Development Advanced Technologies

  • Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
    Director Pilot Plant

  • Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
    Head of Laboratory

  • Fujifilm Diosynth Biotechnologies, UK
    Senior Technical Project Leader

  • SAFC, Germany
    Sales Director, SAFC/EMEA

  • SAFC, Germany
    Business Development Manager, SAFC Contract Manufacturing

  • SAFC, Germany
    Business Development Manager, Contract Manufacturing

  • Bayer Pharma Aktiengesellschaft, Germany
    Head Scale up & Processing

  • Bayer Pharma Aktiengesellschaft, Germany
    Head of GMP Kilolaboratory & HPAI Supply

  • Sicor srl, Italy
    Commercial Highly Potent Products Manager

  • F.P.S. Food and Pharma Systems Srl, Italy
    Sales Manager

  • Lek Pharmaceuticals d.d., Slovenia
    Head Strategic Projects

  • Dietrich Engineering Consultants sa, Switzerland
    Director

  • Medichem Manufacturing (Malta) Limited, Malta
    High Potency Chemist

  • High Potency Chemist, Spain
    Head of Synthesis Laboratories

  • HECHT Technologie GmbH, Germany
    Managing Director

  • Takeda GmbH; Plant Oranienburg, Germany
    Associate Director Analytical Services

  • Ajinomoto OmniChem, Belgium
    Corporate Safety and Health Manager

  • TEVA Pharmaceuticals, Israel
    Senior Director, Technology R&D

  • Hovione Farmaciencia SA, Portugal
    Senior Project Manager, Design Engineering

  • Macfarlan Smith Limited, UK
    Head of EHS

  • JETPHARMA SA, Switzerland
    Business Development Manager

  • UCB Manufactoring Ireland Limited, Ireland
    EHS Director

  • Groupe Novasep, France
    Site Director

  • BSP Pharmaceuticals S.p.A., Italy
    EHS & Toxicology Director